BNET Industries
Market Cap:$44.0B
Last Fiscal Year Sales:$34.1M
- Public
- UK
Dow Jones Description
Corvus was established to identify assets or companies which are either underperforming against established investment criteria or are undervalued in their current form but can be otherwise acquired or tactically repositioned in order to realise potential value. The Corvus management team has the backing of a number international funding partners. Our considered approach over the last decade has created over $600 million of value for investors across a number of investments, either directly or via special purpose investment vehicles.
CEO
Andrew ReganNumber of Employees 18
Peer Companies
NAICS Code Pharmacies and Drug Stores: 446110
News & Analysis
Filter by
cvs corp. and kroger co. - All News and Analysis
Highly Defensive PerformIdex: 35 Stocks to Outpace the Markets
Mike Havrilla submits: The accompanying table presents a quarterly update of my Highly Defensive PerformIdex, with an average beta of 0.72 and a market cap-weighted total return of 7.9% over the past year, outpacing the overall market and ETF peer group -- except for Vanguard Consumer Staples VDC ETF with...
Houston a chain drug hotbed
Top executives from the nation's chain pharmacies frequently visit stores in markets of interest to see firsthand what direct or indirect competitors may be doing that is new or different. A statistical metropolitan service area SMSA that has become a must-see is Houston. The latest thinking from some of...
Twenty-five years at a glance
Viewed from the perspectives of 1978 and 2002, the chain drug industry has undergone revolutionary change. But actually the change has been evolutionary--at least until the consolidation of the 1990s--as the following time line reveals. The recapitulation of highlights from 25 years of Chain Drug Review demonstrates that incremental...
2000 — Retailing in the New Millennium
January * Wal-Mart Stores Inc. and Kmart Corp. announce separate alliances designed to strengthen their positions in the expanding world of Internet-based retailing. Striking first, Kmart reports the formation of a stand-alone E-commerce company, BlueLight.com. The venture, formed in partnership with Softbank Venture Capital and Yahoo! Inc., will provide...
Alternative medicines share stores' shelf space with traditional remedies.
Herbal medicines used to be sold mainly in stores where they might share shelf space with strawberry incense or the latest issue of Mother Earth News. But as more metro Detroiters reach for echinacea to ward off colds and osteobiflex to ease joint pa Herbal medicines...
Mergers alter face of industry
NEW YORK -- Just when it looked as if the merger and acquisition frenzy of the past few years was letting up, a whole new round of deals was struck last year, altering the face of chain drug retailing as it prepares to enter the 21st century. One of...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Andrew Regan | CEO |
| Julian Moore | Executive Director |
| Joanna Barrett | Executive |
| Michael Hirschfield | Executive |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Adrian Collins | Chairman |
| Edward Hanson | Board of Directors |
| Geoffrey Conway-Henderson | Board of Directors |
| Graham Porter | Board of Directors |
| Ian Tickler | Board of Directors |
| John Leat | Board of Directors |
| Richard Griffiths | Board of Directors |
| Simon Fry | Board of Directors |
Andrew Regan, aged 40, joined the Board as Chief Executive of Corvus Capital Inc in September 2004 and over the following year took the company to record profits of 22.1 million in 2005. Andrew sold his original business to Hobson plc in 1991 where he became Chief Executive of Hobson which was listed on the LSE. In 1994 Hobson plc acquired the Co-operative Wholesale Society's food and drinks manufacturing operations and the enlarged Hobson business was eventually sold to Hillsdown Holdings plc for 154 million by way of a recommended takeover in 1996. In 1997 Andrew led an attempt, which subsequently lapsed, to gain control of the CWS in a 1.2 billion take-over bid. Andrew is based in Geneva and he has no other directorships.
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | CEO | Current |
| Corvus Capital Inc | Chief Executive | Current |
Julian is qualified as a chartered accountant with KPMG in Dublin. He has over seven years? experience in the finance industries in the UK, Ireland and South Africa. Julian is an executive director of Corvus Capital (SA) Holdings Limited, which is listed on the Johannesburg Stock Exchange, and is a consultant to CVS Management Limited and Corvus Capital Inc.
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Executive Director | Current |
| Diamondtech Inc | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Executive | Current |
| Diamondtech Inc | Board of Directors | Current |
| Corvus Capital Inc | Director | Current |
Michael qualified as a chartered accountant with Peat Marwick in 1988. He has held senior management positions with a number of public and private companies and has advised Corvus Capital Inc on its Company Secretary Administration since February 2003 and joined the Board as a non-executive director in January 2007.
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Executive | Current |
| Corvus Capital Inc | Board of Directors | Current |
| Peat Marwick International | Chartered Accountant | Former |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Chairman | Current |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Board of Directors | Current |
| Volume | 5,377,835 |
| Shares Outstanding | 1.4B |
| Market Cap | 44.0B |
| Year High | 38.27 |
| Year Low | 23.74 |
| Earnings Per Share | 2.46 |
| P/E Ratio | 12.6829 |
| Dividend | 0.305 |
| Yield | 0.977564 |
Industry Transcripts by Seeking Alpha
-
Conn's Inc. Q3 2009 Earnings Call Transcript
on Nov 25, 2009about CONN
-
Tiffany & Co. F3Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Nov 25, 2009about TIF
-
Coldwater Creek, Inc. Q3 2009 (Qtr End 10/31/09) Earnings Call Transcript
on Nov 24, 2009about CWTR
-
J. Crew Group, Inc. Q3 2009 Earnings Call Transcript
on Nov 24, 2009about JCG
-
Zale Corporation F1Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Nov 24, 2009about ZLC
IndustryTop Rated
- P&G Retail Push Makes Sense, Risks Aside 3 votes
- Walmart Readies Smaller Stores for Smarter Growth 2 votes
- Duckwall-ALCO Rights Itself Amidst Recession 1 votes
- Neil Cole Steps Out From Brother Kenneth's Shadow With Iconix -- Or Does He? 1 votes
- Costco Sees Key Product Categories Turn Positive in September 1 votes




